title: Effects of minimally invasive procedures for evacuation of intracerebral hematoma in early stages on MMP-9 and BBB permeability in rabbits.
abstract: BACKGROUND
  The effects of performing a minimally invasive procedure at different stages after intracerebral hemorrhage on perihematomal MMP-9 expression and blood-brain barrier (BBB) permeability were evaluated.
  
  
  METHODS
  Sixty rabbits were randomly distributed into a model control group (MC group, 30 rabbits) or a minimally invasive group (MI group, 30 rabbits). A model of intracerebral hemorrhage was established in the MC and MI group. In the MI group, the intracerebral hematoma was evacuated by stereotactic minimally invasive procedures over 6 hours (6 rabbits), 12 hours (6 rabbits), 18 hours (6 rabbits) 24 hours or 48 hours (6 rabbits) following successful induction of intracerebral hemorrhage. The same procedure was performed in the MC group at the same time point but without evacuating the hematoma. All the animals were sacrificed within two weeks after the hematoma was surgically evacuated. A neurological deficit score was determined, and the perihematomal MMP-9 level and the BBB permeability were measured.
  
  
  RESULTS
  The neurological deficit score, perihematomal MMP-9 level and BBB permeability of the MI group decreased significantly compared to the MC group. Performing the MI procedure 6-12 h after intracerebral hemorrhage showed the most favorable outcome.
  
  
  CONCLUSIONS
  Regarding the pathophysiological changes surrounding the hematoma, the optimal time window of performing MI procedures for the intracerebral hematoma evacuation might be within 6-12 h after hemorrhage.
authors.affiliation: Emergency Department of Affiliated Hospital, Guiyang Medical College, No, 28, Guiyijie Road, Liuguangmen, Guiyang City, Guizhou Province, 550004 PR China. wuguofeng3013@sina.com.
authors.forename: Guofeng
authors.initials: G
authors.lastname: Wu
authors.forename: Jing
authors.initials: J
authors.lastname: Shi
authors.forename: Fan
authors.initials: F
authors.lastname: Wang
authors.forename: Likun
authors.initials: L
authors.lastname: Wang
authors.forename: Anrong
authors.initials: A
authors.lastname: Feng
authors.forename: Siying
authors.initials: S
authors.lastname: Ren
mesh_terms: D000818:Animals; D001812:Blood-Brain Barrier / Q000473:pathology*; D001834:Body Water; D002543:Cerebral Hemorrhage / Q000201:enzymology / Q000473:pathology / Q000601:surgery*; D008297:Male; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism*; D019060:Minimally Invasive Surgical Procedures / Q000379:methods*; D009422:Nervous System Diseases / Q000209:etiology / Q000473:pathology; D019635:Neurosurgical Procedures / Q000379:methods*; D011817:Rabbits; D013238:Stereotaxic Techniques; D015912:Thrombolytic Therapy
chemical_list: D020780:Matrix Metalloproteinase 9
references.citation: Stroke. 1999 Jun;30(6):1247-55
references.pmid: 10356108
references.citation: Neurocrit Care. 2007;6(1):22-9
references.pmid: 17356187
references.citation: Cerebrovasc Dis. 2012;34(4):249-62
references.pmid: 23052179
references.citation: J Stroke Cerebrovasc Dis. 2013 Apr;22(3):232-40
references.pmid: 21917481
references.citation: Acta Neurochir Suppl. 2008;105:141-5
references.pmid: 19066100
references.citation: Brain Res. 2009 Oct 19;1294:183-92
references.pmid: 19646426
references.citation: Eur J Neurol. 2011 Jan;18(1):158-64
references.pmid: 20550564
references.citation: Br J Neurosurg. 2010 Jun;24(3):268-74
references.pmid: 20465455
references.citation: Curr Treat Options Cardiovasc Med. 2008 Jun;10(3):229-40
references.pmid: 18582412
references.citation: Surg Neurol. 2008 May;69(5):441-6; discussion 446
references.pmid: 18424298
references.citation: Cent Nerv Syst Agents Med Chem. 2011 Jun 1;11(2):150-6
references.pmid: 21521167
references.citation: Neurol Res. 2010 Dec;32(10):1103-9
references.pmid: 20483024
references.citation: Stroke. 2009 Jun;40(6):2199-204
references.pmid: 19359644
references.citation: Neurol Res. 2013 Oct;35(8):829-36
references.pmid: 23676149
references.citation: Neurosurg Clin N Am. 2002 Jul;13(3):349-54
references.pmid: 12486924
references.citation: Stroke. 2008 Apr;39(4):1121-6
references.pmid: 18323498
references.citation: Neurol Res. 2010 May;32(4):371-7
references.pmid: 20483003
references.citation: Acta Neurochir Suppl. 2011;112:3-8
references.pmid: 21691979
references.citation: Zhonghua Yi Xue Za Zhi. 2008 Jan 15;88(3):174-6
references.pmid: 18361815
references.citation: Stroke. 1989 Oct;20(10):1361-7
references.pmid: 2799867
references.citation: Neurol Res. 2011 Apr;33(3):300-6
references.pmid: 20712922
references.citation: Brain Pathol. 2012 Mar;22(2):133-41
references.pmid: 21707819
references.citation: J Stroke Cerebrovasc Dis. 2006 May-Jun;15(3):88-95
references.pmid: 17904058
references.citation: Neurocrit Care. 2011 Feb;14(1):118-26
references.pmid: 21161434
references.citation: J Neurol. 2011 Apr;258(4):661-9
references.pmid: 21340523
references.citation: Neurocrit Care. 2005;3(3):237-45
references.pmid: 16377836
references.citation: Neurochem Int. 2007 Jun;50(7-8):941-53
references.pmid: 17576023
references.citation: Nat Rev Neurol. 2010 Nov;6(11):593-601
references.pmid: 20877400
references.citation: Brain. 2009 Jan;132(Pt 1):26-36
references.pmid: 18772219
references.citation: J Cereb Blood Flow Metab. 2011 Mar;31(3):924-33
references.pmid: 20877384
references.citation: Stroke. 2005 Jul;36(7):1415-20
references.pmid: 15947272
references.citation: Neurol Res. 2008 Oct;30(8):775-82
references.pmid: 18826803
references.citation: Brain Res. 2012 Jul 17;1465:57-65
references.pmid: 22658751
references.citation: Acta Neurochir Suppl. 2008;105:73-7
references.pmid: 19066086
references.citation: Neurol Res. 2010 Mar;32(2):127-33
references.pmid: 19726015